Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

被引:2282
作者
Chang, Tsung-Cheng
Wentzel, Erik A.
Kent, Oliver A.
Ramachandran, Kalyani
Mullendore, Michael
Lee, Kwang Hyuck
Feldmann, Georg
Yamakuchi, Munekazu
Ferlito, Marcella
Lowenstein, Charles J.
Arking, Dan E.
Beer, Michael A.
Maitra, Anirban
Mendell, Joshua T. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
D O I
10.1016/j.molcel.2007.05.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The p53 tumor suppressor protein is a critical regulator of the cellular response to cancer-initiating insults such as genotoxic stress. In this report, we demonstrate that microRNAs (miRNAs) are important components of the p53 transcriptional network. Global miRNA expression analyses identified a cohort of miRNAs that exhibit p53-dependent upregulation following DNA damage. One such miRNA, miR-34a, is commonly deleted in human cancers and, as shown here, frequently absent in pancreatic cancer cells. Characterization of the miR-34a primary transcript and promoter demonstrates that this miRNA is directly transactivated by p53. Expression of miR-34a causes dramatic reprogramming of gene expression and promotes apoptosis. Much like the known set of p53-regulated genes, miR-34a-responsive genes are highly enriched for those that regulate cell-cycle progression, apoptosis, DNA repair, and angiogenesis. Therefore, it is likely that an important function of miR-34a is the modulation and fine-tuning of the gene expression program initiated by p53.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
[1]
The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]
CHD5 is a tumor suppressor at human 1p36 [J].
Bagchi, Anindya ;
Papazoglu, Cristian ;
Wu, Ying ;
Capurso, Daniel ;
Brodt, Michael ;
Francis, Dailia ;
Bredel, Markus ;
Vogel, Hannes ;
Mills, Alea A. .
CELL, 2007, 128 (03) :459-475
[3]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]
BELLO MJ, 1995, INT J CANCER, V64, P207
[5]
BIECHE I, 1993, CANCER RES, V53, P1990
[6]
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias [J].
Bolstad, BM ;
Irizarry, RA ;
Åstrand, M ;
Speed, TP .
BIOINFORMATICS, 2003, 19 (02) :185-193
[7]
Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[8]
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs [J].
Cai, XZ ;
Hagedorn, CH ;
Cullen, BR .
RNA, 2004, 10 (12) :1957-1966
[9]
Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays [J].
Calhoun, Eric S. ;
Hucl, Tomas ;
Gallmeier, Eike ;
West, Kristen M. ;
Arking, Dan E. ;
Maitra, Anirban ;
Iacobuzio-Donahue, Christine A. ;
Chakravarti, Aravinda ;
Hruban, Ralph H. ;
Kern, Scott E. .
CANCER RESEARCH, 2006, 66 (16) :7920-7928
[10]
MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866